The neuromuscular transmission fade (Wedensky inhibition) induced by L-arginine in neuromuscular preparations from rats

General Pharmacology

Volumn 32, Issue 6, 1999, Pages 705-712

  Silva, H M V ^a   Ambiel, C R ^a   Alves Do Prado, W ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

1H 1,2,4 Oxadiazolo 4,3 a quinoxalin 1 one; 3 (4 Morpholinyl) sydonone imine hydrochloride; D Arginine; L Arginine; N( ) Nitro L arginine; Nitric oxide; Skeletal muscle; Tetanic fade; Wedensky inhibition

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE; DEXTRO ARGININE; LINSIDOMINE; N(G) NITROARGININE; TUBOCURARINE CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MALE; MUSCLE CONTRACTION; NERVE CONDUCTION; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; ARGININE; DIAPHRAGM; ELECTRIC STIMULATION; ENZYME INHIBITORS; FEMALE; MALE; MOLSIDOMINE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; NITROARGININE; OXADIAZOLES; PHRENIC NERVE; QUINOXALINES; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 0033033992     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00230-4     Document Type: Article

References (49)

1. Alves-Do-Prado W., Corrado A.P., Prado W.A. Reversal by atropine of tetanic fade induced in cats by antinicotinic and anticholinesterase agents. Anesth Analg. 6:1987;492-496.
2. Ambiel C.R., Alves-Do-Prado W. Neuromuscular facilitation and blockade induced by L-arginine and nitric oxide in the rat isolated diaphragm. Gen Parmac. 28:1997;789-794.
3. Ambiel C.R., Alves-Do-Prado W. Reversal by methylene blue of tetanic fade induced in cats by nitric oxide. Braz J Med Biol Res. 31:1998;413-415.
4. Balon T.W., Nadler J.L. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol. 77:1994;2519-2521.
5. Blaber L.C. The prejunctional action of some nonpolarizing blocking drugs. Br J Pharmac. 47:1973;109-116.
6. Boulton C.L., Southam E., Gartwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703.
7. Bowman W.C. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg. 59:1980;935-943.
8. Bowman W.C., Webb S.N. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cats. Clin Exp Pharmac Physiol. 3:1976;545-555.
9. Brunner F., Scmidt K., Nielsen E.B., Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmac Exp Ther. 227:1996;48-53.
10. Bülbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmac. 1:1946;38-61.
11. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 72:1993;387-395.
12. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J. 14(Suppl. I):1993;123-132.
13. Förstermann U., Nakane M., Tracey W.R., Pollock J.S. Isoforms of nitric oxide synthase. functions in the cardiovascular system Eur Heart J. 14:1993;10-15.
14. Furchgott R.F. Studies on relaxation of rabbit aorta by sodium nitrite. the basis for the proposal that the acid-activable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide Vanhoutte P.M. Vasodilatation. vascular smooth muscle, peptides, autonomic nerves and endothelium:1988;401-414 Raven Press, New York.
15. Furchgott R.F., Zawadski J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
16. Furchgott R.F., Khan M.T., Jothianandan D. Comparison of endothelium-dependent relaxation and nitric oxide-induced relaxation in rabbit aorta. Fed Proc. 46:1987;385.
17. Galley H.F., Webester N.R. Brain nitric oxide synthase activity is decreased by intravenous anesthetics. Anesth Analg. 88:1996;591-594.
18. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and seletive inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazol[4,3-a]quinoxalin-1-one. Mol Pharmac. 48:1995;184-188.
19. Gath I., Closs E.I., Gödtel-Armbrust U., Schmitt S. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle. implications for contractile function FASEB J. 10:1996;1614-1620.
20. Hubbard J.I., Wilson D.F. Neuromuscular transmission in a mammalian preparation in absence of blocking drugs and the effect of d-tubocurarine. J Physiol (Lond). 228:1973;307-325.
21. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem Pharmac. 41:1991;485-490.
22. Ignarro L.J., Adams J.B., Horwitz P.M., Wood K.S. Activation of soluble guanylate cyclase by NO hemoproteins involves NO-heme exchange. J Biol Chem. 261:1986;4997-5002.
23. Ignarro L.J., Buga G.M., Wood K.S., Byrbs R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and release from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
24. Kankaanranta H., Knowles R.G., Vuorinen P., Kosonen O., Holm P., Moilanen E. 3-Morpholino-sydnonimine-induced supression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite. inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine Mol Pharmac. 51:1997;882-888.
25. Khan M.T., Furchgott R.F. Additional evidence that endothelium-derived relaxing factor is nitric oxide. Rand M.J., Roper C. Pharmacology. 1987;341-344 Elsevier, Amsterdam.
26. Kobzik L., Reed M.B., Bredt D.S., Stamler J.S. Nitric oxide in skeletal muscle. Nature. 372:1994;546-548.
27. Kobzik L., Stringer B., Balligand J.L., Reid M.B., Stamler J.S. Endothelial type nitric oxide synthase in skeletal muscle fibers. mitochondrial relationships Biochem Biophys Res Commun. 211:1995;375-381.
28. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase Biochem Biophys Res Commum. 164:1989;678-685.
29. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmac. 45:1993;367-374.
30. 2+-independent synaptic vesicle release. Neuron. 12:1994;1235-1244.
31. Moncada S., Palmer R.M.J., Higgs A. Nitric oxide. physiology, pathophysiology and pharmacology Pharm Rev. 43:1991;109-142.
32. Moritoki H., Ueda H., Yamamoto T., Hisayama T., Takeuchi S. L-Arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation. Br J Pharmac. 102:1991;841-846.
33. Nakane M., Schmidt H.H.H.W., Pollock J.J., Förstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscles. FEBS Lett. 316:1993;1175-1180.
34. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
35. Pérez V.J.R., Menéndez A.L., Cantablanca B., Sánchez M., Hidalgo A. Nitric oxide and cyclic nucleotides participate in the relation of diclofenac on rat uterine smooth muscle. Gen Pharmac. 30:1998;25-29.
36. Plane F., Hurrel A., Jeremy J.Y., Garland C.J. Evidence that potassium channels make a major contribution to SIN-1-evoked relaxation of rat isolated mesenteric artery. Br J Pharmac. 119:1996;1557-1562.
37. Pollock J.S., Förstermann U., Mitchell J.A., Warner T.D., Schmidt H.H.H.W., Nakane M., Murad F. Purification and characterization of particular endothelium-derived relaxing factor synthase form cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1991;10480-10484.
38. Rao V.L., Butterworth R.F. L-[3H]Nitroarginine and L-[3H]arginine uptake into rat cerebellar synaptossomes. kinetics and pharmacology J Neurochem. 67:1996;1275-1281.
39. Ribera J., Marsal J., Casanovas A., Hukkanen M., Tarabal O., Esquerda J.E. Nitric oxide synthase in rat neuromuscular junctions and in nerve terminals of Torpedo electric organ. its role as regulator of acetylcholine release J Neurosci Res. 51:1998;90-102.
40. Sakuma I., Stueher D.J., Gross S.S., Nathen C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 85:1988;8664-8667.
41. 2+-calmodulin-regulated nitric oxide synthases. Cell Calcium. 13:1992;427-434.
42. Schmidt H.H.H.W., Gagne G.D., Nakane M., Pollock J.S., Meller M.F., Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent colocalization with NAPH diaphorase, but not with soluble guanyly cyclase, and novel paraneural functions of nitrinergic signal transduction. J Histochem Cytochem. 40:1993;1439-1456.
43. Schmidt H.H.H.W., Sieb J., Clement B., Feelisch M. 1H[1,2,4]Oxadiazol[4,3-A]quinoxalin-1-one (ODQ) is not a selective inhibitor of soluble guanylyl cyclase. interference with NO-synthase and nitrovasodilator biotransformation Br J Pharmac. 123:1998;6. p.
44. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmac. 50:1996;1-5.
45. Shimizu S., Yamamoto T., Momose K. Inhibition by methylene blue of L-arginine metabolism to citruline coupled with nitric oxide synthesis in cultured endothelial cells. Chem Pathol Pharmac. 82:1993;35-48.
46. Southam E., Garthwaite J. Comparative effects of some nitric oxide donors on cyclic GMP level in rat cerebellar slices. Neurosci Lett. 130:1991;107-111.
47. Thompson M., Becker L., Bryant D., Williams G., Levin D., Margraf L., Giroir B.P. Expression of the inducible nitric oxide synthase gene in diaphragm and skeletal muscle. J Appl Physiol. 81:1996;2415-2420.
48. Van der Kloot W., Molgó J. Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol Rev. 4:1994;899-991.
49. Wascher T.C., Posch K., Wallner S., Hermetter A., Kostener G.M., Graier W.F. Vascular effects of L-arginine. Anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commum. 234:1997;35-38.